Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?

Analytical and Quantitative Cytology and Histology

Volumn 34, Issue 5, 2012, Pages 264-272

  Antunes, Armando Jr ^a   Andrade, L A L A ^a   Pinto, G A ^a   Leão, Rogerio ^a   Pinto Neto, A M ^a   Costa Paiva, Lúcia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bcl 2; COX 2; Endometrial polyp; Immunohistochemistry; Ki 67; Postmenopause

Indexed keywords

ANGIOGRAPHY; ANGIOSCOPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CATHETER; CLINICAL RESEARCH; EARLY DIAGNOSIS; HUMAN; IMAGING SYSTEM; INFRARED MICROSPECTROMETER; INTRAVASCULAR ULTRASOUND; MICROSCOPY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NONINVASIVE ULTRASOUND; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RAMAN MICROSPECTROMETER; RAMAN SPECTROMETRY; SCREENING TEST; SPECTROMETER; SPECTROPHOTOMETER; SPECTROSCOPY; ULTRASOUND; VALIDATION STUDY; VIBRATIONAL SPECTROSCOPY;

AGED; APOPTOSIS; CELL PROLIFERATION; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASMS; POLYPS; POSTMENOPAUSE; PRECANCEROUS CONDITIONS; PREVALENCE; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 84869138417     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Perez-Medina T, Bajo J, Huertas MA, Rubio A Predicting atypia inside endometrial polyps. J Ultrasound Med 2002;21: 125-128
2. La Torre R, De Felice C, De Angelis C, Coacci F, Mastrone M, Cosmi EV Transvaginal sonographic evaluation of endometrial polyps: A comparison with two-dimensional and threedimensional contrast sonography. Clin Exp Obstet Gynecol 1999;26:171-173
3. Haimov-Kochman R, Deri-Hasid R, Hamani Y, Voss E The natural course of endometrial polyps: Could they vanish when left untreated? Fertil Steril 2009;92:828.e11-828.e12
4. Lee SC, Kaunitz AM, Ramos LS, Rhatigan RM The oncogenic potential of endometrial polyps: A systematic review and meta-analysis. Obstet Gynecol 2010;116:1197-1205
5. Lieng M, Istre O, Qvigstad E Treatment of endometrial polyps: A systematic review. Acta Obstet Gynecol Scand 2010;89:992-1002
6. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P Endometrial carcinoma: Association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch 2001;438:470-477
7. Bokhman JV Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17
8. Mertens HJ, Heineman MJ, Evers JL The expression of apoptosis-related proteins Bcl-2 and Ki-67 in endometrium of ovulatory menstrual cycles. Gynecol Obstet Invest 2002; 53:224-230
9. Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, Kandiloglu AR, Caglar H, Fraser IS Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 2006;61:24-28
10. Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson M Dissociated expression of Bcl-2 and Ki67 in endometrial lesions: Diagnostic and histogenetic implications. Int J Gynecol Pathol 2002;21:155-160
11. Morsi HM, Leers MP, Jäger W, Björklund V, Radespiel-Tröger M, El Kabarity H, Nap M, Lang N The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic and malignant endometrium. Int J Gynecol Pathol 2000;19:118-126
12. Hachisuga T, Hideshima T, Kawarabayashi T, Eguchi F, Emoto M, Shirakusa T Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen treated endometrium. Int J Gynecol Pathol 1999;18:297-303
13. McGurgan P, Taylor LJ, Duffy SR, O'Donovan PJ Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre-and postmenopausal women. Maturitas 2006;54:277-284
14. Tokyol C, Aktepe F, Dilek FH, Sahin O, Arioz DT Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol 2009;28:148-156
15. Maia H Jr, Pimentel K, Silva TM, Freitas LA, Zausner B, Athayde C, Coutinho EM Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol 2006;22:219-224
16. Maia H Jr, Maltez A, Studard E, Zausner B, Athayde C, Coutinho E Effect of menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol 2005;21:57-61
17. Chandrasekharan NV, Simmons DL The cyclooxygenases. Genome Biol 2004;5:241-247
18. Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 2000;164: 820-825
19. Rozic JG, Chakraborty C, Lala PK Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer 2001;93:497-506
20. Ferrandina G, Lauriola L, Zannoni GF, Fagotti A, Fanfani F, Legge F, Maggiano N, Gessi M, Mancuso S, Ranelletti FO, Scambia G Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol 2002;13:1205-1211
21. Sinicrope FA, Gills S Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev 2004;23:63-75
22. Maia JR H, Correia T, Freitas LA, Athayde C, Coutinho E Cyclooxygenase-2 expression in endometrial polyps during menopause. Gynecol Endocrinol 2005;21:336-339
23. Fons G, Hasibuan SM, van der Velden J, Ten Kate FJ Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol 2007;60:500-503
24. Harvey JM, Clark GM, Osbome CK, Allred DC Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17: 1474-1481
25. Costa-Paiva L, Godoy CE Jr, Antunes A Jr, Caseiro JD, Arthuso M, Pinot-Neto AM Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause 2011;18:1-5
26. Taylor LJ, Jackson TL, Reid JG, Duffy SR The differential expression of ER, PR, Bcl-2 and Ki-67 in endometrial polyps. BJOG 2003;110:794-798
27. McGurgan P, Taylor LJ, Duffy SR, O'Donovan PJ An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT. Maturitas 2006;53:454-461
28. Amalinei C, Cianga C, Balan R, Cianga P, Giusca S, Caruntu ID Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. Ann Anat 2011;193:43-55
29. Sakuragi N, Salah-eldin AE, Watari H, Itoh T, Inoue S, Moriuchi T, Fujimato S Bax, Bcl-2 and p53 expression in endometrial cancer. Gynecol Oncol 2002;86:288-296
30. Ioffe OB, Papadimitriou JC, Drachenberg CB Correlation of proliferation indices, apoptosis and related oncogene expression (bcl-2 and c-erB-2) and p53 in proliferative, hyperplastic and malignant endometrium. Hum Pathol 1998;29: 1150-1159
31. Catasus L, Matias-Guiu X, Matchin P, Munoz J, Prat J BAX somatic frameshift mutations in endometrioid adenocarcionomas of the endometrium: Evidence for a tumor progression role in endometrial carcinomas with microsatellite instability. Lab Invest 1998;78:1439-1444
32. Altaner S, Gucer F, Tokatli F, Guresci S, Ozdemir C, Puyan FO, Kutlu K Expression of Bcl-2 and Ki-67 in tamoxifenassociated endometrial polyps: Comparison with postmenopausal polyps. Onkologie 2006;29:376-380
33. O'Banion MK, Winn VD, Yound DA cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci U S A 1992;89:4888-4892
34. Bulun SE, Zeitoun KM, Takayama K, Sasano H Molecular basis for treating endometriosis with aromatase inhibitors. Hum Reprod Update 2000;6:413-418
35. Erdemoglu E, Güney M, Karahan N, Mungan T Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas 2008;59:268-274
36. Tamura M, Sebastian S, Yang S, Gurates B, Ferrer K, Sasano H, Okamura K, Bulun SE Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells: A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B. J Biol Chem 2002;277:26208-26216
37. Li W, Xu RJ, Zhang HH, Jiang LH Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer 2006;16:1673-1678
38. Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Darai E Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer 2006;16:1911-1917
39. McCarty KS Jr, Miller LS, Cox EB, Konrath J, McCarty KS Sr Estrogen receptor analyses: Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985;109:716-21